Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactions.

Autor:	Wen, J.1, Li, R.2, Lu, Y.2, Shupnik, M. A.1,3
Zdroj:	Oncogene. 1/29/2009, Vol. 28 Issue 4, p575-586. 12p. 6 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu